Blue Origin Recovers from New Glenn Rocket Explosion

Jeff Bezos’ aerospace company, Blue Origin, announced that the recent rocket explosion at Cape Canaveral Space Force Station did not damage some critical components of their launch infrastructure. The New Glenn rocket, essential to NASA’s Artemis moon program, experienced a significant explosion during an engine test.

The blast resulted in the destruction of a lightning tower and the transporter-erector used for rocket movement and assembly. Despite the damage, CEO Dave Limp noted that the methane, hydrogen, and oxygen tanks remained intact, as did a nearby water tank. Additionally, the support tower is repairable, and nearby booster and rocket components were unharmed.

Acknowledging the fortunate outcome, Limp conveyed optimism in an update shared on X, stating: “We will fly again before the end of this year.” The exact cause of the explosion is under investigation.

NASA recently awarded Blue Origin a substantial contract for the New Glenn rockets to launch two moon rovers prior to the arrival of Artemis moonwalkers. These rockets are also crucial for deploying Blue Origin’s Blue Moon lander, intended for future astronaut missions to the lunar surface. NASA’s plans include a moon landing as early as 2028, marking the first since Apollo 17 in 1972.

Administrator Jared Isaacman expressed NASA’s commitment to reinstating the launch pad swiftly while prioritizing progress on the lunar lander development. Blue Origin’s New Glenn series of reusable rockets, named after astronaut John Glenn, has launched three times. While not as large as SpaceX’s Starship, New Glenn plays a critical role in upcoming lunar missions.

Starship rockets, currently conducting test flights from Texas, are also part of NASA’s plans to transport Artemis astronauts to the lunar surface. The collaborative efforts between Blue Origin and SpaceX aim to advance space exploration in the coming years.

This content has been independently reported by the Associated Press. The Health and Science Department benefits from support provided by the Howard Hughes Medical Institute and the Robert Wood Johnson Foundation.